Editas Medicine (EDIT) FY 2025 Conference September 03, 2025 08:00 AM ET Speaker0Our lead development candidate, Edit 401. This webinar is being recorded and can be accessed in the future through this same link or through the Investors section of the company's website. After our prepared remarks, we will open the call to Q&A. To ask a question, please click the raise hand feature in the webinar portal. As a reminder, various remarks that we make during this presentation about the company's future expectatio ...

Editas Medicine (EDIT) Update / Briefing September 02, 2025 08:00 AM ET Company ParticipantsDana Sheehan - Associate Director - Corporate CommunicationsGilmore O’Neill - Director, President & CEOLinda Burkly - EVP & Chief Scientific OfficerAlec Stranahan - VP - Equity ResearchBill Maughan - MD, Equity Research - BiotechnologyJonathan Miller - MD - Biotech & Pharma Equity ResearchSoumit Roy - MD - HealthcareTony Deng - VP - Biotechnology Equity ResearchConference Call ParticipantsJack Allen - Senior Research ...